Le Dr Mustafa Serkan Alemdar est spécialisé en oncologie médicale, avec un accent particulier sur le traitement du cancer du rein au Complexe Hospitalier Medical Park Antalya.
Le professeur agrégé Nail Paksoy est spécialisé en chimiothérapie du cancer du rein à l'hôpital Medipol Bahçelievler, avec un accent mis sur les cas réfractaires et les nouvelles thérapies.
Le Prof. Assoc. Atakan Topcu est spécialisé dans les thérapies ciblées et l'immunothérapie pour le cancer du rein à l'Hôpital de District Medipol Acibadem.
Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).
She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).
Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.
He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.
Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.
Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).
Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).
Professeur agrégé d'oncologie médicale à l'Hôpital Liv Topkapı de l'Université İstinye – spécialisé dans la chimiothérapie du cancer du rein, avec de nombreuses publications de recherche.
Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.
He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.
His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.
He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.
Le Dr Shruti Kate est spécialisée dans la chimiothérapie avancée du cancer du rein, avec une expertise en immunothérapie et en thérapie métronomique au HCG Manavata Cancer Centre.
Le Dr Raj Nagarkar a pratiqué plus de 50 000 chirurgies oncologiques avec 19 ans d'expérience, se spécialisant en oncologie chirurgicale mammaire et thoracique.
Le Dr Shaunak Valame est spécialisé dans les traitements du cancer à base moléculaire et a présenté ses recherches à l'American Society of Clinical Oncology.
Plus de 10 000 chirurgies majeures réussies – Le Dr Lalit se concentre sur les techniques minimalement invasives pour les chirurgies du cancer avec d'excellents résultats.
Le Dr Ahmer Arif Shaikh est spécialisé en oncologie chirurgicale, avec un accent particulier sur le cancer buccal, la préservation des organes et la réadaptation fonctionnelle au HCG Manavata Cancer Centre.
Le Dr Borde a traité plus de 30 000 TEP et 1 000 patients atteints de cancer de la thyroïde au HCG Manavata Cancer Centre.
Le Dr Sridhar P.S. est spécialisé en radiothérapie pour le cancer du rein au HCG Manavata Cancer Centre, avec plus de 20 ans d'expérience.
Le professeur Tolga Akman est spécialisé dans le traitement du cancer du rein à l'hôpital Medicana Bahcelievler, y compris la néphrectomie radicale et partielle.